D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Pacific Biosciences
PACB
$375M
| $9.6M | 0.01% |
721,632
+106,381
| +17% | +$1.41M |
|
|
SPWR
802
DELISTED
SunPower Corporation Common Stock
SPWR
| $9.56M | 0.01% |
975,831
+140,702
| +17% | +$1.38M |
|
|
MORF
803
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $9.55M | 0.01% |
166,608
+106,592
| +178% | +$6.11M |
|
804
Moderna
MRNA
$9.87B
| $9.54M | 0.01% |
78,507
-189,573
| -71% | -$23M |
|
805
Armstrong World Industries
AWI
$8.61B
| $9.54M | 0.01% |
129,801
+124,393
| +2,300% | +$9.14M |
|
806
Resideo Technologies
REZI
$5.48B
| $9.52M | 0.01% |
539,268
+22,747
| +4% | +$402K |
|
807
Arrow Electronics
ARW
$6.65B
| $9.52M | 0.01% |
66,450
-97,294
| -59% | -$13.9M |
|
808
D.R. Horton
DHI
$54B
| $9.51M | 0.01% |
78,129
-188,850
| -71% | -$23M |
|
|
MRTX
809
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.5M | 0.01% |
262,938
+17,352
| +7% | +$627K |
|
810
Nova
NVMI
$8.54B
| $9.49M | 0.01% |
80,885
+18,393
| +29% | +$2.16M |
|
811
Acadia Healthcare
ACHC
$2.06B
| $9.45M | 0.01% |
118,673
+46,761
| +65% | +$3.72M |
|
812
Avanos Medical
AVNS
$574M
| $9.45M | 0.01% |
369,565
-147,816
| -29% | -$3.78M |
|
813
Bath & Body Works
BBWI
$5.76B
| $9.44M | 0.01% |
251,771
+76,701
| +44% | +$2.88M |
|
814
Winnebago Industries
WGO
$985M
| $9.4M | 0.01% |
140,937
-1,409
| -1% | -$94K |
|
815
Pulmonx
LUNG
$69.3M
| $9.39M | 0.01% |
716,378
+142,214
| +25% | +$1.86M |
|
816
Brady Corp
BRC
$3.76B
| $9.35M | 0.01% |
+196,494
| New | +$9.35M |
|
817
Nasdaq
NDAQ
$55B
| $9.34M | 0.01% |
187,300
-363,606
| -66% | -$18.1M |
|
818
Expeditors International
EXPD
$16.8B
| $9.33M | 0.01% |
77,057
+37,973
| +97% | +$4.6M |
|
819
Moody's
MCO
$93.1B
| $9.33M | 0.01% |
26,832
+12,434
| +86% | +$4.32M |
|
820
Badger Meter
BMI
$5.35B
| $9.32M | 0.01% |
63,192
+55,243
| +695% | +$8.15M |
|
821
Alcon
ALC
$39.4B
| $9.32M | 0.01% |
113,553
-295,860
| -72% | -$24.3M |
|
822
Allegro MicroSystems
ALGM
$5.55B
| $9.26M | 0.01% |
205,129
-172,183
| -46% | -$7.77M |
|
823
AvidXchange
AVDX
$2.06B
| $9.25M | 0.01% |
891,092
-371,681
| -29% | -$3.86M |
|
824
Canadian Imperial Bank of Commerce
CM
$73.9B
| $9.21M | 0.01% |
215,786
+156,486
| +264% | +$6.68M |
|
825
Analog Devices
ADI
$122B
| $9.18M | 0.01% |
47,136
-60,814
| -56% | -$11.8M |
|